# Kristin Pareja

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/kristin-pareja/

## Facts

| Field | Value |
| --- | --- |
| Citations | 67 |
| Field | Genetic and Kidney Cyst Diseases |
| h-index | 4 |
| i10-index | 2 |
| Last Known Institution | Otsuka (United States) |
| OpenAlex ID | https://openalex.org/A5063680270 |
| Works | 10 |

## Researcher papers

- [Antipsychotic-Related Stigma and the Impact on Treatment Choices: A Systematic Review and Framework Synthesis](https://scholariq.org/papers/antipsychotic-related-stigma-and-the-impact-on-treatment-choices-a-systematic/)
- [Review on epidemiology, disease burden, and treatment patterns of IgA nephropathy in select APAC countries](https://scholariq.org/papers/review-on-epidemiology-disease-burden-and-treatment-patterns-of-iga-nephropathy/)
- [Readmissions, costs, and duration to subsequent outpatient visit after hospital discharge among Medicaid beneficiaries utilizing oral versus long-acting injectable antipsychotics in bipolar disorder or schizophrenia](https://scholariq.org/papers/readmissions-costs-and-duration-to-subsequent-outpatient-visit-after-hospital/)
- [Health Disparities in Kidney Failure Among Patients With Autosomal Dominant Polycystic Kidney Disease: A Cross-Sectional Study](https://scholariq.org/papers/health-disparities-in-kidney-failure-among-patients-with-autosomal-dominant/)
- [Data driven approach to characterize rapid decline in autosomal dominant polycystic kidney disease](https://scholariq.org/papers/data-driven-approach-to-characterize-rapid-decline-in-autosomal-dominant-2/)
- [Data Driven Approach to Characterize Rapid Decline in Autosomal Dominant Polycystic Kidney Disease](https://scholariq.org/papers/data-driven-approach-to-characterize-rapid-decline-in-autosomal-dominant/)
- [Social Determinants of Health (SDOH) and Healthcare Resource Utilization (HRU) in Autosomal Dominant Polycystic Kidney Disease (ADPKD) by CKD Stage](https://scholariq.org/papers/social-determinants-of-health-sdoh-and-healthcare-resource-utilization-hru-in/)
- [Early Real-World Descriptive Findings on Tolvaptan-Treated Patients with Autosomal Dominant Polycystic Kidney Disease in the United States](https://scholariq.org/papers/early-real-world-descriptive-findings-on-tolvaptan-treated-patients-with/)
- [Early Findings of Patients with Autosomal Dominant Polycystic Kidney Disease Initiating Tolvaptan in the United States: A Claims-Based Analysis](https://scholariq.org/papers/early-findings-of-patients-with-autosomal-dominant-polycystic-kidney-disease/)
- [Global Real-World Evidence of Tolvaptan in Patients with Autosomal Dominant Polycystic Kidney Disease (ADPKD)](https://scholariq.org/papers/global-real-world-evidence-of-tolvaptan-in-patients-with-autosomal-dominant/)

## Researcher topics

- [Genetic and Kidney Cyst Diseases](https://scholariq.org/topics/genetic-and-kidney-cyst-diseases/)
- [Renal Diseases and Glomerulopathies](https://scholariq.org/topics/renal-diseases-and-glomerulopathies/)
- [Schizophrenia research and treatment](https://scholariq.org/topics/schizophrenia-research-and-treatment/)
- [Renal and related cancers](https://scholariq.org/topics/renal-and-related-cancers/)
- [Mental Health Treatment and Access](https://scholariq.org/topics/mental-health-treatment-and-access/)

## Researcher university

- [Otsuka (United States)](https://scholariq.org/institutions/otsuka-united-states/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.